Growth footprint Small, specialized CRO with five sites in Ohio and Tennessee and a track record of hundreds of studies; opportunity to expand geographic reach and add more sponsors through regional expansion and co-development opportunities.

Sponsor network Currently works with over 75 sponsors; potential to target mid-market pharma and biotech clients seeking nimble CRO partners for late-stage trials or specialized therapeutic areas.

Industry positioning Focus on bringing new therapies to market aligns with sponsors pursuing innovative programs; leverage this narrative to upsell higher-complexity studies and faster study startup capabilities.

Digital presence Tech stack includes WordPress and analytics tools; opportunities to optimize digital channels for lead generation, case studies, and targeted campaigns aimed at sponsor decision-makers.

Financials signal Revenue under $1M indicates a high-growth, high-potential partner suitable for tiered engagement models, joint ventures, or multi-project contracts with scalable services as sponsor demand grows.